Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Head and Neck Neoplasms 2Wilms Tumor 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Retinoblastoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasm Metastasis 1Lymphoma 1Liver Neoplasms 1Kidney Neoplasms 1Fibrosarcoma 1Esophageal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Dendritic Cell Sarcoma, Interdigitating 1Chondrosarcoma 1Burkitt Lymphoma 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 4spartalizumab 2tislelizumab 1obinutuzumab 1naptumomab estafenatox 1durvalumab 1Topotecan 1Rosiglitazone 1Nivolumab 1Metformin 1Gemcitabine 1Cisplatin 1Carboplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Topotecan × Head & Neck × Clear all
NCT00252889 2009-01-27

Doxil Topotecan Doublet Cancer Study

Christiana Care Health Services

Phase 1 Completed
20 enrolled
GastrointestinalHead & NeckThoracic

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡